Updates are available Correction dated 2024-04-02
Click to view Correction: https://doi.org/10.1007/s00134-024-07394-8
-
Authors
Tomasello, Mara
Mangioni, Davide https://orcid.org/0000-0002-7431-5019
Panigada, Mauro
Matinato, Caterina
Bandera, Alessandra
- License Information
-
More Information
Article History
Accepted: 24 February 2024
First Online: 18 March 2024
Change Date: 2 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00134-024-07394-8
Declarations
:
: MT declared there are no conflicts of interest; DM received speaker’s honoraria from Pfizer and MSD and received travel grants from Pfizer; MP declared there are no conflicts of interest; CM declared there are no conflicts of interest; and AB received speaker’s honoraria and fees for attending advisory boards from AstraZeneca, bioMérieux, Janssen-Cilag, Nordic Pharma, Pfizer, QIAGEN, Sobi, and ViiV and received research grants from Gilead.
: This clinical study was approved by the Milan Area 2 Ethical Committee (#97_2021). We received informed consent from participants or their proxies. All data processing was performed according to the Declaration of Helsinki.
